Monocytes, eosinophils, natural killer (NK) cells, and CD8− DCs likewise increased in number following imatinib treatment with or without infection, though to a lesser extent than neutrophils (Figs. 1A,B; S1C). The gene discussed is CD8A; the disease is infection.